Skip to main content
. 2020 Jul 1;9(7):2064. doi: 10.3390/jcm9072064

Table 4.

Definition and management of bleeding in patients on dual antiplatelet therapy (modified from European Guidelines [7]). DAPT, dual antiplatelet therapy; GI, gastrointestinal; GU, genitourinary; Hb, hemoglobin; i.v., intravenous; Plt, Platelets; PPI, proton pump inhibitor; RBC, red blood cell; SAPT, single antiplatelet therapy.

Severity Grade Definition Examples DAPT Management Other Recommendations
Trivial Any bleeding not requiring medical intervention or further evaluation Skin bruising, ecchymosis, self-resolving epistaxis, minimal conjunctival bleeding Continue DAPT Reassure the patient
Identify preventive strategies
Drug-adherence counselling
Mild Any bleeding that requires medical attention without requiring hospitalization Not self-resolving epistaxis, moderate conjunctival bleeding, GU or GI bleeding without significant blood loss, mild hemoptysis Continue DAPT
Consider shortening DAPT duration
Consider DAPT de-escalation
Identify and treat bleeding-related conditions
Add PPI if not present
Drug adherence counselling
Moderate Any bleeding associated with a significant blood loss (>3 g/dL Hb) and/or requiring hospitalization, hemodynamically stable and not evolving GU, respiratory or GI bleeding with significant blood loss or requiring blood transfusion Consider switching from DAPT to SAPT
Reinitiate DAPT as soon as deemed safe
Consider DAPT de-escalation
Consider shortening DAPT duration
Identify and treat bleeding-related conditions
i.v. PPI if GI bleeding
Drug adherence counselling
Severe Any bleeding requiring hospitalization, associated with a severe blood loss (>5 g/dL Hb), hemodynamically stable and not rapidly evolving Severe GU, respiratory or GI bleeding. Consider switching from DAPT to SAPT
If bleeding persists despite treatment, consider stopping APT
Re-evaluate need of APT once bleeding has ceased
Consider shortening DAPT duration
Consider DAPT de-escalation
RBC if Hb < 7–8 g/dL
Consider Plt transfusion
Urgent treatment of bleeding source if possible
i.v. PPI if GI bleeding
Life-threatening Any severe active bleeding putting patient’s life immediately at risk Massive overt GU, respiratory or GI bleeding, active intracranial, spinal or intraocular hemorrhage, or any bleeding causing hemodynamic instability Immediately discontinue all APT
Re-evaluate need of APT once bleeding has ceased.
Fluid replacement
RBC and Plt transfusion
Urgent treatment of bleeding source if possible
i.v. PPI if GI bleeding